1. The clinical significance of food-drug interactions: a review;Neuvonen;Therapeutics,1989
2. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors;Bocan;Biochim Biophys Acta,1992
3. Safety, tolerance and pharmacokinetic profiles following single-doses of CI-981, a potent HMG-CoA reductase inhibitor (abstract PPDM 8134);Cilla;Pharm Res,1993
4. Single- and multiple-dose pharmacokinetics of CI-981, a potent HMG-CoA reductase inhibitor (abstract PPDM 8167);Whitfield;Pharm Res,1993
5. Lovastatin: a new cholesterol-lowering agent;McKenny;Clin Pharm,1988